The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal cancer, one of the deadliest types of cancers that has been rising in ...

Bristol Myers Squibb said Monday it will pay the German firm BioNTech billions of dollars to split rights for an experimental cancer drug called BNT327, which works on both PD-L1, the target of ...

Woman diagnosed with colon cancer initially thought she had IBS symptoms 02:35. Colon cancer patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early detection and prevention.

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

Katie Thurston is going through the wringer in her Stage 4 breast cancer battle.. The “Bachelorette” alum, 34, gave a heartbreaking health update in an Instagram video posted Sunday. “I just ...

To do that, researchers used a blood test to find mutations in cancer cells that let the tumors defy standard treatments. Early detection allowed patients to be switched to a different drug that ...

Dr. Janjigian can be contacted at [email protected] or at Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, BAIC Rm. 1001, 300 E. 66th St., New York, NY 10065.